Dr. Mason is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
105 Londonderry Ct
Reno, NV 89511Phone+1 775-849-9910
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Cardiovascular Disease, 1974 - 1976- Stanford Health Care-Sponsored Stanford UniversityInternship, Internal Medicine, 1973 - 1974
- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1972 - 1972
Perelman School of Medicine at the University of PennsylvaniaClass of 1972
Certifications & Licensure
CA State Medical License 1973 - 2026
UT State Medical License 1983 - 2026
KY State Medical License 1999 - 2025
NV State Medical License 1986 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1983
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Myocarditis Treatment Trial Start of enrollment: 1986 Jul 01
- Race Difference Moxifloxacin-induced QT Prolongation Between Healthy Chinese and Caucasian Volunteers Start of enrollment: 2014 Apr 01
Publications & Presentations
PubMed
- 1 citationsSurface Electrocardiographic Parameters of Children and Adolescents Diagnosed with Attention-Deficit/Hyperactivity Disorder in an Ambulatory Community Pediatric Center...Fernando A. Isart, Jay W. Mason, Fernando J. Isart-Infante, Faustino G. Ramos
Journal of Child and Adolescent Psychopharmacology. 2021-02-25 - 7 citationsImmunoglobulin Free Light Chains as Inflammatory Biomarkers of Atrial Fibrillation.Akira Matsumori, Toshio Shimada, Miho Shimada, Hideo Otani, Mark T. Drayson
Circulation. Arrhythmia and Electrophysiology. 2020-10-05 - 12 citationsImmunoglobulin free light chains as an inflammatory biomarker of heart failure with myocarditis.Akira Matsumori, Toshio Shimada, Eiji Nakatani, Miho Shimada, Steven Tracy
Clinical Immunology. 2020-08-01
Press Mentions
HUYABIO Validates Protective Mechanism for Antiarrhythmic Drug HBI-3000 in AF Patients, Paving the Way for a New Era in Atrial Fibrillation TreatmentNovember 14th, 2024
Spaulding Clinical Research Awarded Five-Year Contract with FDAFebruary 27th, 2020- aha/acc/hrs Scientific StatementsFebruary 1st, 2020
- Join now to see all
Grant Support
- Long QT SyndromeNational Center For Research Resources2004–2005
- Arrhythmia Gene VariantsNational Center For Research Resources2004
- Therapy Of Repolarization AbnormalitiesNational Heart, Lung, And Blood Institute2000–2002
- Repolarization Changes Associated With Ventricular Arrhythmias And Sudden DeathNational Heart, Lung, And Blood Institute1995–1999
- SCOR In Sudden Cardiac DeathNational Heart, Lung, And Blood Institute1995–1998
- Training In Cardiovascular ResearchNational Heart, Lung, And Blood Institute1985–1998
- Comparison Of Electrophysiologic Study To ECG MonitoringNational Heart, Lung, And Blood Institute1985–1992
- Immunosuppressive Therapy For Biopsy-Proven MyocarditisNational Heart, Lung, And Blood Institute1986–1991
- Cardiovascular And Renal Study SectionCenter For Scientific Review1986–1988
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
